US Patent Issued to Starton Therapeutics on Aug. 19 for "Stable solutions of immunomodulatory imide compounds for parenteral use" (New York, North Carolina Inventors)

ALEXANDRIA, Va., Aug. 20 -- United States Patent no. 12,390,457, issued on Aug. 19, was assigned to Starton Therapeutics Inc. (Paramus, N.J.).

"Stable solutions of immunomodulatory imide compounds for parenteral use" was invented by Rod L. Hartwig (Sloatsburg, N.Y.), Arturo Serrano-Batista (Sloatsburg, N.Y.) and James Oliver (Raleigh, N.C.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are compositions comprising a stable solution of an immune-mediated inflammatory disease (IMID) agent, such as an immunomodulatory imide drug (IMiD) including, but not limited to, lenalidomide (LLD). More particularly, embodiments relate to stable solutions of IMiDs for parenteral use. Methods of preparing stable solu...